Hepatobiliary & Pancreatic Diseases International
搜索
Hepatobiliary & Pancreatic Diseases International
2020年6期
浏览往期
订阅
目录
Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis
Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management
Safety and efficacy of an integrated endovascular treatment strategy for early hepatic artery occlusion after liver transplantation
Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection
Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia
Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells
Preservation of platelet function in patients with cirrhosis and thrombocytopenia undergoing esophageal variceal ligation
Changes in thyroid function in patients with liver failure and their clinical significance: A clinical study of non-thyroidal illness syndrome in patients with liver failure
Long noncoding RNA HAND2-AS1 re duce d the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis
Diagnostic accuracy of administrative database for bile duct cancer by ICD-10 code in a tertiary institute in Korea
Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas ✩
Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancreatic cancer
Increased CMTM4 mRNA expression predicts a poor prognosis in patients with hepatocellular carcinoma
Serum non-high-density lipoprotein cholesterol level is increased in Chinese patients with nonalcoholic fatty liver disease
Non-operative management of pancreatic trauma in adults
Thanks
Meetings and Courses
Hepatobiliary&Pancreatic Diseases International